glembatumumab (102)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVQLQESGPG LVKPSQTLSL TCTVSGGSIS SFNYYWSWIR HHPGKGLEWI  50

GYIYYSGSTY SNPSLKSRVT ISVDTSKNQF SLTLSSVTAA DTAVYYCARG 100

YNWNYFDYWG QGTLVTVSSA STKGPSVFPL APCSRSTSES TAALGCLVKD 150

YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSNFGTQTY 200

TCNVDHKPSN TKVDKTVERK CCVECPPCPA PPVAGPSVFL FPPKPKDTLM 250

ISRTPEVTCV VVDVSHEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTFRV 300

VSVLTVVHQD WLNGKEYKCK VSNKGLPAPI EKTISKTKGQ PREPQVYTLP 350

PSREEMTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPMLDSDG 400

SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK      445

Light chain / Chaone lygire / Cadena ligera

EIVMTQSPAT LSVSPGERAT LSCRASQSVD NNLVWYQQKP GQAPRLLIYG  50

ASTRATGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YNNWPPWTFG 100

QGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK 150

VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ 200

GLSSPVTKSF NRGEC                                       215

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-97	146-202	259-319	365-423

	22??-97??	146??-202??	259??-319??	365??-423??

Intra-L	23?-88?	135?-195?



	23???-88???	135???-195???



Inter-H-L	133-215?	133??-215???



Inter-H-H	221-221??	222-222??	225-225??	228-228??



N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

295, 295??

CAS		1020264-78-1

Description

immunoglobulin G2-kappa, anti-[Homo sapiens GPNMB (glycoprotein
transmembrane NMB, hematopoietic growth factor inducible neurokinin-1
type, HGFIN) extracellular domain], Homo sapiens monoclonal antibody; 

gamma2 heavy chain (1-445) [Homo sapiens VH (IGHV4-31*02 (94.90%)
-(IGHD)-IGHJ4*01) [10.7.11] (1-119) -IGHG2*01 (120-445)],
(133-215?)-disulfide with kappa light chain (1?-215?) [Homo sapiens
V-KAPPA (IGKV3-15*01 (96.80%) -IGKJ1*01) [6.3.10] (1?-108?) -IGKC*01
(109?-215?)];
(221-221??:222-222??:225-225??:228-228??)-tetrakisdisulfide dimer

immunoglobuline G2-kappa, anti-[Homo sapiens GPNMB (glycoprotyine
transmembranaire NMB, facteur de croissance hymatopopytique inductible
type neurokinine-1, HGFIN) domaine extracellulaire], Homo sapiens
anticorps monoclonal; 

chaone lourde gamma2 (1-445) [Homo sapiens VH (IGHV4-31*02 (94.90%)
-(IGHD)-IGHJ4*01) [10.7.11] (1-119) -IGHG2*01 (120-445)],
(133-215?)-disulfure avec la chaone lygire kappa (1?-215?) [Homo sapiens
V-KAPPA (IGKV3-15*01 (96.80%) -IGKJ1*01) [6.3.10] (1?-108?) -IGKC*01
(109?-215?)]; dimire
(221-221??:222-222??:225-225??:228-228??)-tytrakisdisulfure 

inmunoglobulina G2-kappa, anti-[Homo sapiens GPNMB (glicoprotenna
transmembranosa NMB, factor de crecimiento hematopoyytico inductible
tipo neuroquinina-1, HGFIN) dominio extracelular], Homo sapiens
anticuerpo monoclonal; 

cadena pesada gamma2 (1-445) [Homo sapiens VH (IGHV4-31*02
(94.90%)-(IGHD)-IGHJ4*01) [10.7.11] (1-119) -IGHG2*01 (120-445)],
(133-215?)-disulfuro con la cadena ligera kappa (1?-215?) [Homo sapiens
V-KAPPA (IGKV3-15*01 (96.80%)-IGKJ1*01) [6.3.10] (1?-108?) -IGKC*01
(109?-215?)]; dnmero
(221-221??:222-222??:225-225??:228-228??)-tetrakisdisulfuro 

	

WHO 

International Nonproprietary Names Programme	

15/01/2010

9199

		

